Long-term survival and late deaths after allogeneic bone marrow transplantation

New England Journal of Medicine

Volumn 341, Issue 1, 1999, Pages 14-21

  Socié, Gérard ^a   Stone, Judith Veum ^b   Wingard, John R ^c   Weisdorf, Daniel ^d   Henslee Downey, P Jean ^e   Bredeson, Christopher ^f   Cahn, Jean Yves ^g   Passweg, Jakob R ^h   Rowlings, Philip A ^b   Schouten, Harry C ⁱ   Kolb, Hans Jochem ^j   Klein, John P ^b   Horowitz, Mary M ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY HOSPITAL OF BESANÇON   (France)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^j LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DEATH; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENT CANCER; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MORTALITY; RECURRENCE; RISK; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033168009     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199907013410103     Document Type: Article

References (29)

1. Horowitz MM, Rowlings PA. An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation. Curr Opin Hematol 1997;4:395-400.
2. Zittoun RA, Mandelli F, Willemze R, et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 1995;332:217-23.
3. Barrett AJ, Horowitz MM, Pollock BH, et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994;331:1253-8.
4. Goldman JM. Optimizing treatment for chronic myeloid leukemia. N Engl J Med 1997;337:270-1.
5. Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. Blood 1995;85:3367-77.
6. Passweg JR, Socié G, Hinterberger W, et al. Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997;90: 858-64.
7. Kernan NA, Bartsch G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993;328:593-602.
8. Henslee-Downey PJ, Abhyankar SH, Parrish RS, et al. Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997;89:3864-72.
9. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
10. Klein JP, Moeschberger ML. Survival analysis: techniques for censored and truncated data. New York: Springer-Verlag, 1997.
11. Andersen PK, Vaeth M. Simple parametric and nonparametric models for excess and relative mortality. Biometrics 1989;45:523-35.
12. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330: 827-38.
13. Beatty PG. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases: report of a symposium, 14 March 1996, Washington, D.C. Exp Hematol 1997;25:1195-208.
14. Duell T, van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation. Ann Intern Med 1997;126:184-92.
15. Hudson MM, Jones D, Boyett J, Sharp GB, Pui CH. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997;15:2205-13.
16. Nicholson HS, Fears TR, Byrne J. Death during adulthood in survivors of childhood and adolescent cancer. Cancer 1994;73:3094-102.
17. Robertson CM, Hawkins MM, Kingston JE. Late deaths and survival after childhood cancer: implications for cure. BMJ 1994;309:162-6.
18. Green DM, Zevon MA, Reese PA, Lowrie GS, Michalek AM. Factors that influence the further survival of patients who survive for five years after the diagnosis of cancer in childhood or adolescence. Med Pediatr Oncol 1994;22:91-6. [Erratum, Med Pediatr Oncol 1996;26:72.]
19. Hawkins MM, Kingston JE, Kinnier Wilson LMK. Late deaths after treatment for childhood cancer. Arch Dis Child 1990;65:1356-63.
20. de Lima M, Strom SS, Keating M, et al. Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work. Blood 1997;90:4719-24.
21. Freireich EJ, Keating MJ. Conclusions regarding leukemia long-term survival. Cancer 1997;80:Suppl:2215-7.
22. Appelbaum FR, Kopecky KJ. Long-term survival after chemotherapy for acute mycloid leukemia: the experience of the Southwest Oncology Group. Cancer 1997;80:Suppl:2199-204.
23. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED, eds. Bone marrow transplantation. Cambridge, Mass.: Blackwell Scientific, 1994:339-62.
24. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 1997;54:131-8.
25. Deeg HJ, Leisenring W, Storb R, et al. Long-term outcome after marrow transplantation for severe aplastic anemia. Blood 1998;91:3637-45.
26. Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904.
27. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:2041-50.
28. Collins RH Jr, Shpilberg O, Drobyski WR, et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997;15:433-44.
29. Cella DF, Bonomi AE. Measuring quality of life: 1995 update. Oncology (Huntingt) 1995;9:Suppl:47-60.